# COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy

> **NCT02278068** · NA · COMPLETED · sponsor: **Metavention** · enrollment: 46 (actual)

## Conditions studied

- Diabetes
- Endocrine, Nutritional and Metabolic Diseases (E00-E89)

## Interventions

- **DEVICE:** Metabolic Neuromodulation System (MNS)

## Key facts

- **NCT ID:** NCT02278068
- **Lead sponsor:** Metavention
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02278068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02278068, "COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02278068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*